Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
SIO Requested Updates to NCCN Guidelines
06/27/2023
Washington, DC (27 June 2023) — The Society of Interventional Oncology requested the updates to NCCN guidelines below:  NCCN Soft Tissue Sarcoma Guidelines The Society of Interventional Oncology submitted updates to the...
Washington, DC (27 June 2023) — The Society of Interventional Oncology requested the updates to NCCN guidelines below:  NCCN Soft Tissue Sarcoma Guidelines The Society of Interventional Oncology submitted updates to the...
Washington, DC (27 June 2023) —...
06/27/2023
IO Learning
News
SIR and Congressional Men’s Health Caucus Collaborate on PAE Briefing
06/26/2023
Washington, DC (26 June 2023) — On 5 June, the Society of Interventional Radiology (SIR) held a briefing in Washington DC, USA, of which the focus was benign prostate hyperplasia (BPH). The briefing took place in conjunction with the US...
Washington, DC (26 June 2023) — On 5 June, the Society of Interventional Radiology (SIR) held a briefing in Washington DC, USA, of which the focus was benign prostate hyperplasia (BPH). The briefing took place in conjunction with the US...
Washington, DC (26 June 2023) —...
06/26/2023
IO Learning

Advertisement

News
Surmodics Receives FDA Approval for the SurVeil Drug-coated Balloon
06/26/2023
Prairie, MN (26 June 2023) — Surmodics has announced the receipt of US Food and Drug Administration (FDA) approval for the SurVeil drug-coated balloon (DCB). A company press release notes that the SurVeil DCB may now be marketed...
Prairie, MN (26 June 2023) — Surmodics has announced the receipt of US Food and Drug Administration (FDA) approval for the SurVeil drug-coated balloon (DCB). A company press release notes that the SurVeil DCB may now be marketed...
Prairie, MN (26 June 2023)...
06/26/2023
IO Learning
News
Launch of Robotic Surgery at the Alexandra Hospital in Redditch
06/26/2023
Redditch, England (26 June 2023) — The first 50 patients have undergone prostate cancer treatment using state-of-the-art robotic surgery at the Alexandra Hospital in Redditch. Arrival of the surgical robot in September marked a...
Redditch, England (26 June 2023) — The first 50 patients have undergone prostate cancer treatment using state-of-the-art robotic surgery at the Alexandra Hospital in Redditch. Arrival of the surgical robot in September marked a...
Redditch, England (26 June 2023)...
06/26/2023
IO Learning
News
Telix to Acquire Lightpoint Medical
06/26/2023
Melbourne, AU (26 June 2023) — Telix Pharmaceuticals Limited announced it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a United Kingdom-based medical...
Melbourne, AU (26 June 2023) — Telix Pharmaceuticals Limited announced it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a United Kingdom-based medical...
Melbourne, AU (26 June 2023) —...
06/26/2023
IO Learning

Advertisement

News
Titan Medical Successfully Transitions to IP licensing company
06/26/2023
Toronto, CA (26 June 2023) — Titan Medical Inc. is pleased to provide this further corporate update on its successful transition to an IP licensing company. Given the state of the capital markets such that emerging tech issuers have...
Toronto, CA (26 June 2023) — Titan Medical Inc. is pleased to provide this further corporate update on its successful transition to an IP licensing company. Given the state of the capital markets such that emerging tech issuers have...
Toronto, CA (26 June 2023) —...
06/26/2023
IO Learning
News
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion
06/20/2023

Telix Press Release

Telix Press Release
Melbourne, AU (19 June 2023) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company’s carbonic anhydrase- (CAIX)-targeting PET/CT imaging agent...
Melbourne, AU (19 June 2023) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company’s carbonic anhydrase- (CAIX)-targeting PET/CT imaging agent...
Melbourne, AU (19 June 2023) —...
06/20/2023
IO Learning
Dr. Zach Berman, Dr. Anne Covey, and Haley Leopold, MD
News
SIO Talk Tuesdays: IO Research Protocol Essentials: Idea to Investigator-Initiated Study (IIS)
06/19/2023

SIO News

SIO News
Washington, DC (19 June 2023) — The second Talk Tuesday session will be hosted tomorrow online by SIO featuring Dr. Zach Berman, Dr. Anne Covey, and Haley Leopold, MD. Get ready for an engaging and enlightening discussion on the...
Washington, DC (19 June 2023) — The second Talk Tuesday session will be hosted tomorrow online by SIO featuring Dr. Zach Berman, Dr. Anne Covey, and Haley Leopold, MD. Get ready for an engaging and enlightening discussion on the...
Washington, DC (19 June 2023) —...
06/19/2023
IO Learning

Advertisement

News
Medivis Raises $20M Series A to Advance Surgery With Augmented Reality
06/19/2023
Newswise Press Release
New York, NY (13 June 2023) — Medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million Series A funding round led by Thrive Capital, with...
New York, NY (13 June 2023) — Medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million Series A funding round led by Thrive Capital, with...
New York, NY (13 June 2023)...
06/19/2023
IO Learning
News
Researchers Test AI-Powered Chatbot's Medical Diagnostic Ability
06/19/2023
Newswise Press Release
Boston, MA (19 June 2023) — In a recent experiment published in JAMA, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) tested one well-known publicly available chatbot’s ability to make accurate diagnoses in...
Boston, MA (19 June 2023) — In a recent experiment published in JAMA, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) tested one well-known publicly available chatbot’s ability to make accurate diagnoses in...
Boston, MA (19 June 2023)...
06/19/2023
IO Learning

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use